Shawn D. Harmon

979 total citations
17 papers, 824 citations indexed

About

Shawn D. Harmon is a scholar working on Biochemistry, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Shawn D. Harmon has authored 17 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 9 papers in Molecular Biology and 6 papers in Nutrition and Dietetics. Recurrent topics in Shawn D. Harmon's work include Eicosanoids and Hypertension Pharmacology (11 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Fatty Acid Research and Health (6 papers). Shawn D. Harmon is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (11 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Fatty Acid Research and Health (6 papers). Shawn D. Harmon collaborates with scholars based in United States and France. Shawn D. Harmon's co-authors include Arthur A. Spector, Terry L. Kaduce, Neal L. Weintraub, Xiang Fang, Bruce D. Hammock, Deborah E. Williard, Shanming Hu, John R. Falck, Lynn M. Teesch and Steven A. Moore and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Lipid Research.

In The Last Decade

Shawn D. Harmon

17 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shawn D. Harmon United States 13 601 299 223 206 195 17 824
M VanRollins United States 13 629 1.0× 303 1.0× 289 1.3× 129 0.6× 235 1.2× 15 1.0k
Wolf-Hagen Schunck Germany 13 347 0.6× 196 0.7× 204 0.9× 99 0.5× 121 0.6× 16 652
S. Kametani Japan 11 228 0.4× 213 0.7× 156 0.7× 50 0.2× 82 0.4× 20 558
Alicia Sánchez-Mendoza Mexico 17 182 0.3× 193 0.6× 252 1.1× 66 0.3× 51 0.3× 47 777
Seyhan Şahan-Fırat Türkiye 17 250 0.4× 139 0.5× 268 1.2× 58 0.3× 39 0.2× 40 692
Tricia M. Miller United States 11 212 0.4× 110 0.4× 181 0.8× 65 0.3× 46 0.2× 14 529
Marilyn A. Isbell United States 11 262 0.4× 176 0.6× 126 0.6× 159 0.8× 22 0.1× 13 622
Susana Nowicki Argentina 14 200 0.3× 196 0.7× 285 1.3× 38 0.2× 38 0.2× 29 555
C. Kemal Buharalıoğlu Türkiye 16 191 0.3× 104 0.3× 189 0.8× 40 0.2× 38 0.2× 30 580
Ami Oguro Japan 16 210 0.3× 87 0.3× 199 0.9× 79 0.4× 47 0.2× 44 610

Countries citing papers authored by Shawn D. Harmon

Since Specialization
Citations

This map shows the geographic impact of Shawn D. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shawn D. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shawn D. Harmon more than expected).

Fields of papers citing papers by Shawn D. Harmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shawn D. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shawn D. Harmon. The network helps show where Shawn D. Harmon may publish in the future.

Co-authorship network of co-authors of Shawn D. Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Shawn D. Harmon. A scholar is included among the top collaborators of Shawn D. Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shawn D. Harmon. Shawn D. Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fang, Xiang, Frank M. Faraci, Terry L. Kaduce, et al.. (2006). 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. American Journal of Physiology-Heart and Circulatory Physiology. 291(5). H2301–H2307. 37 indexed citations
2.
Harmon, Shawn D., Xiang Fang, Terry L. Kaduce, et al.. (2006). Oxygenation of ω-3 fatty acids by human cytochrome P450 4F3B: Effect on 20-hydroxyeicosatetraenoic acid production. Prostaglandins Leukotrienes and Essential Fatty Acids. 75(3). 169–177. 35 indexed citations
3.
Fang, Xiang, Joseph S. Dillon, Shanming Hu, et al.. (2006). 20-Carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors α and γ. Prostaglandins & Other Lipid Mediators. 82(1-4). 175–184. 31 indexed citations
4.
Fang, Xiang, Shanming Hu, Gary D. Snyder, et al.. (2005). 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-α. American Journal of Physiology-Heart and Circulatory Physiology. 290(1). H55–H63. 93 indexed citations
5.
Harmon, Shawn D., Terry L. Kaduce, Xiang Fang, et al.. (2005). ω-Oxidation of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Cerebral Microvascular Smooth Muscle and Endothelium by Alcohol Dehydrogenase 4. Journal of Biological Chemistry. 280(39). 33157–33164. 42 indexed citations
6.
Fang, Xiang, Neal L. Weintraub, Shanming Hu, et al.. (2004). Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. American Journal of Physiology-Heart and Circulatory Physiology. 287(6). H2412–H2420. 75 indexed citations
7.
Chen, Ping, Shanming Hu, Shawn D. Harmon, et al.. (2004). Metabolism of anandamide in cerebral microvascular endothelial cells. Prostaglandins & Other Lipid Mediators. 73(1-2). 59–72. 9 indexed citations
8.
Kaduce, Terry L., Xiang Fang, Shawn D. Harmon, et al.. (2004). 20-Hydroxyeicosatetraenoic Acid (20-HETE) Metabolism in Coronary Endothelial Cells. Journal of Biological Chemistry. 279(4). 2648–2656. 49 indexed citations
10.
Williard, Deborah E., Shawn D. Harmon, T L Kaduce, & Arthur A. Spector. (2002). Comparison of 20-, 22-, and 24-carbon n-3 and n-6 polyunsaturated fatty acid utilization in differentiated rat brain astrocytes. Prostaglandins Leukotrienes and Essential Fatty Acids. 67(2-3). 99–104. 11 indexed citations
11.
Fang, Xiang, Neal L. Weintraub, Christine L. Oltman, et al.. (2002). Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. American Journal of Physiology-Heart and Circulatory Physiology. 283(6). H2306–H2314. 38 indexed citations
12.
Fang, Xiang, Terry L. Kaduce, Neal L. Weintraub, et al.. (2001). Pathways of Epoxyeicosatrienoic Acid Metabolism in Endothelial Cells. Journal of Biological Chemistry. 276(18). 14867–14874. 175 indexed citations
13.
Williard, Deborah E., Joseph O. Nwankwo, Terry L. Kaduce, et al.. (2001). Identification of a fatty acid Δ6-desaturase deficiency in human skin fibroblasts. Journal of Lipid Research. 42(4). 501–508. 63 indexed citations
14.
Williard, Deborah E., Shawn D. Harmon, Terry L. Kaduce, et al.. (2001). Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. Journal of Lipid Research. 42(9). 1368–1376. 88 indexed citations
15.
Williard, Deborah E., Shawn D. Harmon, Meredith A. Preuss, et al.. (2000). Production and Release of Docosahexaenoic Acid by Differentiated Rat Brain Astrocytes. World review of nutrition and dietetics. 88. 168–172. 10 indexed citations
16.
Harmon, Shawn D., et al.. (2000). Paramecium Calmodulin Mutants Defective in Ion Channel Regulation Can Bind Calcium and Undergo Calcium-Induced Conformational Switching. Biochemistry. 39(23). 6881–6890. 11 indexed citations
17.
Williard, Deborah E., Terry L. Kaduce, Shawn D. Harmon, & Arthur A. Spector. (1998). Conversion of eicosapentaenoic acid to chain-shortened omega–3 fatty acid metabolites by peroxisomal oxidation. Journal of Lipid Research. 39(5). 978–986. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026